Recce Pharmaceuticals Ltd logo

Recce Pharmaceuticals Ltd (RCE)

Market Open
ASX ASX
137.36M Market Cap
- P/E Ratio
- Div Yield
54,492 Volume
-0.09 Eps
Want to track RCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
2 Mar 2026
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
29 Aug 2025
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
23 Jul 2025
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
25 Feb 2025
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
7 Nov 2024
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
30 Aug 2024
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
29 Jul 2024
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
22 Apr 2024
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
26 Feb 2024
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
20 Oct 2023
-
-
Recce Pharmaceuticals Ltd logo
RCE Recce Pharmaceuticals Ltd
25 Aug 2016
-
-

RCE Earnings Reports FAQ

What is the earnings per share (EPS) for RCE?

The current EPS is -0.09.

What is the company's earnings growth rate?

Recce Pharmaceuticals Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Recce Pharmaceuticals Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Recce Pharmaceuticals Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for RCE at this time, as Recce Pharmaceuticals Ltd has no recent EPS data to calculate it.